
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Medullary Thyroid Carcinoma in MEN2A: ATA Moderate- or High-Risk RET Mutations Do Not Predict Disease Aggressiveness
Rachel K. Voss, Lei Feng, Jeffrey E. Lee, et al.
The Journal of Clinical Endocrinology & Metabolism (2017) Vol. 102, Iss. 8, pp. 2807-2813
Open Access | Times Cited: 57
Rachel K. Voss, Lei Feng, Jeffrey E. Lee, et al.
The Journal of Clinical Endocrinology & Metabolism (2017) Vol. 102, Iss. 8, pp. 2807-2813
Open Access | Times Cited: 57
Showing 1-25 of 57 citing articles:
GDNF and the RET Receptor in Cancer: New Insights and Therapeutic Potential
Lois M. Mulligan
Frontiers in Physiology (2019) Vol. 9
Open Access | Times Cited: 107
Lois M. Mulligan
Frontiers in Physiology (2019) Vol. 9
Open Access | Times Cited: 107
Multiple endocrine neoplasia type 2: A review
Jes Sloth Mathiesen, Grigoris Effraimidis, Maria Rossing, et al.
Seminars in Cancer Biology (2021) Vol. 79, pp. 163-179
Closed Access | Times Cited: 65
Jes Sloth Mathiesen, Grigoris Effraimidis, Maria Rossing, et al.
Seminars in Cancer Biology (2021) Vol. 79, pp. 163-179
Closed Access | Times Cited: 65
A comprehensive review on MEN2B
Fréderic Castinetti, Jeffrey Moley, Lois M. Mulligan, et al.
Endocrine Related Cancer (2017) Vol. 25, Iss. 2, pp. T29-T39
Open Access | Times Cited: 83
Fréderic Castinetti, Jeffrey Moley, Lois M. Mulligan, et al.
Endocrine Related Cancer (2017) Vol. 25, Iss. 2, pp. T29-T39
Open Access | Times Cited: 83
Hereditary and familial thyroid tumours
Julie Guilmette, Vânia Nosé
Histopathology (2017) Vol. 72, Iss. 1, pp. 70-81
Closed Access | Times Cited: 83
Julie Guilmette, Vânia Nosé
Histopathology (2017) Vol. 72, Iss. 1, pp. 70-81
Closed Access | Times Cited: 83
Survival and Long-Term Biochemical Cure in Medullary Thyroid Carcinoma in Denmark 1997–2014: A Nationwide Study
Jes Sloth Mathiesen, Jens Peter Kroustrup, Peter Vestergaard, et al.
Thyroid (2019) Vol. 29, Iss. 3, pp. 368-377
Open Access | Times Cited: 56
Jes Sloth Mathiesen, Jens Peter Kroustrup, Peter Vestergaard, et al.
Thyroid (2019) Vol. 29, Iss. 3, pp. 368-377
Open Access | Times Cited: 56
The clinical practice guidelines for primary hyperparathyroidism, short version
Н. Г. Мокрышева, Anna Eremkina, Svetlana Mirnaya, et al.
Problems of Endocrinology (2021) Vol. 67, Iss. 4, pp. 94-124
Open Access | Times Cited: 47
Н. Г. Мокрышева, Anna Eremkina, Svetlana Mirnaya, et al.
Problems of Endocrinology (2021) Vol. 67, Iss. 4, pp. 94-124
Open Access | Times Cited: 47
Updates on the genetics of multiple endocrine neoplasia
Nicolas Sahakian, Frédéric Castinetti, Pauline Romanet, et al.
Annales d Endocrinologie (2024) Vol. 85, Iss. 2, pp. 127-135
Closed Access | Times Cited: 8
Nicolas Sahakian, Frédéric Castinetti, Pauline Romanet, et al.
Annales d Endocrinologie (2024) Vol. 85, Iss. 2, pp. 127-135
Closed Access | Times Cited: 8
Serum Biochemical Markers for Medullary Thyroid Carcinoma: An Update
Shuzhou Liu, Hao Zhao, Xiaoyi Li
Cancer Management and Research (2024) Vol. Volume 16, pp. 299-310
Open Access | Times Cited: 6
Shuzhou Liu, Hao Zhao, Xiaoyi Li
Cancer Management and Research (2024) Vol. Volume 16, pp. 299-310
Open Access | Times Cited: 6
Update on Multiple Endocrine Neoplasia Type 2: Focus on Medullary Thyroid Carcinoma
Friedhelm Raue, Karin Frank‐Raue
Journal of the Endocrine Society (2018) Vol. 2, Iss. 8, pp. 933-943
Open Access | Times Cited: 50
Friedhelm Raue, Karin Frank‐Raue
Journal of the Endocrine Society (2018) Vol. 2, Iss. 8, pp. 933-943
Open Access | Times Cited: 50
Draft of clinical guidelines for the diagnosis and treatment of primary hyperparathyroidism in adult patients
И. И. Дедов, G. А. Melnichenko, Н. Г. Мокрышева, et al.
Endocrine Surgery (2023) Vol. 16, Iss. 4, pp. 5-54
Open Access | Times Cited: 13
И. И. Дедов, G. А. Melnichenko, Н. Г. Мокрышева, et al.
Endocrine Surgery (2023) Vol. 16, Iss. 4, pp. 5-54
Open Access | Times Cited: 13
Prophylactic thyroidectomy in children with multiple endocrine neoplasia type 2
Francesco Paolo Prete, Tarek Abdel‐Aziz, Clare Morkane, et al.
British journal of surgery (2018) Vol. 105, Iss. 10, pp. 1319-1327
Open Access | Times Cited: 41
Francesco Paolo Prete, Tarek Abdel‐Aziz, Clare Morkane, et al.
British journal of surgery (2018) Vol. 105, Iss. 10, pp. 1319-1327
Open Access | Times Cited: 41
Multilayered heterogeneity as an intrinsic hallmark of neuroendocrine tumors
Sergio Pedraza‐Arévalo, Manuel D. Gahete, Emilia Alors‐Pérez, et al.
Reviews in Endocrine and Metabolic Disorders (2018) Vol. 19, Iss. 2, pp. 179-192
Closed Access | Times Cited: 41
Sergio Pedraza‐Arévalo, Manuel D. Gahete, Emilia Alors‐Pérez, et al.
Reviews in Endocrine and Metabolic Disorders (2018) Vol. 19, Iss. 2, pp. 179-192
Closed Access | Times Cited: 41
Influencers on Thyroid Cancer Onset: Molecular Genetic Basis
Berta Luzón‐Toro, Raquel M. Fernández, Leticia Villalba‐Benito, et al.
Genes (2019) Vol. 10, Iss. 11, pp. 913-913
Open Access | Times Cited: 41
Berta Luzón‐Toro, Raquel M. Fernández, Leticia Villalba‐Benito, et al.
Genes (2019) Vol. 10, Iss. 11, pp. 913-913
Open Access | Times Cited: 41
MEN2-related pheochromocytoma: current state of knowledge, specific characteristics in MEN2B, and perspectives
Vincent Amodru, David Taïeb, Carole Guérin, et al.
Endocrine (2020) Vol. 69, Iss. 3, pp. 496-503
Closed Access | Times Cited: 34
Vincent Amodru, David Taïeb, Carole Guérin, et al.
Endocrine (2020) Vol. 69, Iss. 3, pp. 496-503
Closed Access | Times Cited: 34
Pediatric Medullary Thyroid Carcinoma: Clinical Presentations and Long-Term Outcomes in 144 Patients Over 6 Decades
S Hensley, Mimi I. Hu, Roland L. Bassett, et al.
The Journal of Clinical Endocrinology & Metabolism (2024) Vol. 109, Iss. 9, pp. 2256-2268
Closed Access | Times Cited: 4
S Hensley, Mimi I. Hu, Roland L. Bassett, et al.
The Journal of Clinical Endocrinology & Metabolism (2024) Vol. 109, Iss. 9, pp. 2256-2268
Closed Access | Times Cited: 4
Approach to the Patient: Hereditary Medullary Thyroid Carcinoma
Omair A. Shariq, Steven G. Waguespack, Sarah Hamidi, et al.
The Journal of Clinical Endocrinology & Metabolism (2025)
Open Access
Omair A. Shariq, Steven G. Waguespack, Sarah Hamidi, et al.
The Journal of Clinical Endocrinology & Metabolism (2025)
Open Access
Hereditary Medullary Thyroid Cancer: Genotype–Phenotype Correlation
Karin Frank‐Raue, Friedhelm Raue
Recent results in cancer research/Recent Results in Cancer Research (2025), pp. 183-209
Closed Access
Karin Frank‐Raue, Friedhelm Raue
Recent results in cancer research/Recent Results in Cancer Research (2025), pp. 183-209
Closed Access
Long-Term Survivorship in Multiple Endocrine Neoplasia Type 2B Diagnosed Before and in the New Millennium
Friedhelm Raue, Henning Dralle, Andreas Machens, et al.
The Journal of Clinical Endocrinology & Metabolism (2017) Vol. 103, Iss. 1, pp. 235-243
Open Access | Times Cited: 38
Friedhelm Raue, Henning Dralle, Andreas Machens, et al.
The Journal of Clinical Endocrinology & Metabolism (2017) Vol. 103, Iss. 1, pp. 235-243
Open Access | Times Cited: 38
Genotype and phenotype landscape of MEN2 in 554 medullary thyroid cancer patients: the BrasMEN study
Rui M. B. Maciel, Cleber Camacho, Lígia Vera Montali da Assumpção, et al.
Endocrine Connections (2019) Vol. 8, Iss. 3, pp. 289-298
Open Access | Times Cited: 35
Rui M. B. Maciel, Cleber Camacho, Lígia Vera Montali da Assumpção, et al.
Endocrine Connections (2019) Vol. 8, Iss. 3, pp. 289-298
Open Access | Times Cited: 35
Medullary thyroid carcinoma: recent advances in identification, treatment, and prognosis
Marisa A. Bartz-Kurycki, Omowunmi E. Oluwo, Lilah F. Morris
Therapeutic Advances in Endocrinology and Metabolism (2021) Vol. 12
Open Access | Times Cited: 25
Marisa A. Bartz-Kurycki, Omowunmi E. Oluwo, Lilah F. Morris
Therapeutic Advances in Endocrinology and Metabolism (2021) Vol. 12
Open Access | Times Cited: 25
65 YEARS OF THE DOUBLE HELIX: Exploiting insights on the RET receptor for personalized cancer medicine
Lois M. Mulligan
Endocrine Related Cancer (2018) Vol. 25, Iss. 8, pp. T189-T200
Open Access | Times Cited: 28
Lois M. Mulligan
Endocrine Related Cancer (2018) Vol. 25, Iss. 8, pp. T189-T200
Open Access | Times Cited: 28
Long-Term Outcomes and Aggressiveness of Hereditary Medullary Thyroid Carcinoma: 40 Years of Experience at One Center
Friedhelm Raue, Thomas Brückner, Karin Frank‐Raue
The Journal of Clinical Endocrinology & Metabolism (2019) Vol. 104, Iss. 10, pp. 4264-4272
Open Access | Times Cited: 27
Friedhelm Raue, Thomas Brückner, Karin Frank‐Raue
The Journal of Clinical Endocrinology & Metabolism (2019) Vol. 104, Iss. 10, pp. 4264-4272
Open Access | Times Cited: 27
Molecular Basis and Natural History of Medullary Thyroid Cancer: It is (Almost) All in the RET
Nicolas Sahakian, Frédéric Castinetti, Pauline Romanet
Cancers (2023) Vol. 15, Iss. 19, pp. 4865-4865
Open Access | Times Cited: 7
Nicolas Sahakian, Frédéric Castinetti, Pauline Romanet
Cancers (2023) Vol. 15, Iss. 19, pp. 4865-4865
Open Access | Times Cited: 7
Diagnostic characteristics, treatment patterns, and clinical outcomes for patients with advanced/metastatic medullary thyroid cancer
Rohan Parikh, Lisa M. Hess, Elizabeth Esterberg, et al.
Thyroid Research (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Rohan Parikh, Lisa M. Hess, Elizabeth Esterberg, et al.
Thyroid Research (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Fifty years of thyroid pathology: concepts and developments
Zubair Baloch, Virginia A. LiVolsi
Human Pathology (2019) Vol. 95, pp. 46-54
Closed Access | Times Cited: 17
Zubair Baloch, Virginia A. LiVolsi
Human Pathology (2019) Vol. 95, pp. 46-54
Closed Access | Times Cited: 17